Insider Transactions in Q3 2021 at Personalis, Inc. (PSNL)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 17
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,088
-1.32%
|
$22,848
$21.25 P/Share
|
Sep 17
2021
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
3,152
-1.67%
|
$66,192
$21.25 P/Share
|
Sep 14
2021
|
John Stephen West President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
100,000
-6.4%
|
$2,100,000
$21.97 P/Share
|
Sep 02
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
291
-0.35%
|
$6,111
$21.92 P/Share
|
Sep 02
2021
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
3,820
-1.98%
|
$80,220
$21.92 P/Share
|
Aug 26
2021
|
John Stephen West President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
77,272
+8.93%
|
$0
$0.44 P/Share
|
Aug 19
2021
|
John Stephen West President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
115,228
-13.95%
|
$1,843,648
$16.81 P/Share
|
Aug 19
2021
|
John Stephen West President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
115,228
+12.25%
|
$0
$0.44 P/Share
|
Aug 06
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
4,436
-5.11%
|
$93,156
$21.22 P/Share
|
Aug 06
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Exercise of conversion of derivative security
|
Direct |
15,564
-15.2%
|
$326,844
$21.18 P/Share
|
Aug 06
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
15,564
+13.19%
|
-
|
Jul 27
2021
|
Aaron Tachibana CFO AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+4.94%
|
-
|
Jul 27
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+10.53%
|
-
|
Jul 15
2021
|
John Stephen West President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+9.55%
|
$0
$0.44 P/Share
|
Jul 08
2021
|
John Stephen West President and CEO |
SELL
Open market or private sale
|
Direct |
110,000
-14.75%
|
$2,420,000
$22.54 P/Share
|
Jul 08
2021
|
John Stephen West President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+12.86%
|
$0
$0.44 P/Share
|